Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Fate Therapeutics Inc shares valued at $9,269 were sold by Bressi Jerome Charles on Jan 10 ’25. At $1.55 per share, Bressi Jerome Charles sold 5,980 shares. The insider’s holdings dropped to 270,203 shares worth approximately $0.34 million following the completion of this transaction.
Also, TAHL CINDY sold 5,654 shares, netting a total of over 8,764 in proceeds. Following the sale of shares at $1.55 each, the insider now holds 336,707 shares.
Before that, Valamehr Bahram had sold 8,705 shares from its account. In a trade valued at $13,406, the President and CEO traded Fate Therapeutics Inc shares for $1.54 each. Upon closing the transaction, the insider’s holdings decreased to 8,705 shares, worth approximately $0.44 million.
As published in a research note from BofA Securities on November 18, 2024, Fate Therapeutics Inc [FATE] has been rated up from an Underperform to a Neutral. Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid June. Earlier on January 24, 2023, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for FATE stock which previously was a “a Buy”.
Analyzing FATE Stock Performance
During the last five days, there has been a drop of approximately -25.15%. Over the course of the year, Fate Therapeutics Inc shares have dropped approximately -24.24%. Shares of the company reached a 52-week high of $1.9900 on 01/06/25 and a 52-week low of $1.0400 on 01/14/25. A 50-day SMA is recorded $2.1035, while a 200-day SMA reached $3.4722. Nevertheless, trading volume fell to 1.68 million shares from 2.11 million shares the previous day.
Support And Resistance Levels for Fate Therapeutics Inc (FATE)
According to the 24-hour chart, there is a support level at 1.2067, which, if violated, would cause prices to drop to 1.1633. In the upper region, resistance lies at 1.3067. The next price resistance is at 1.3633. RSI (Relative Strength Index) is 30.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2936, which suggests the price will decrease in the coming days. Percent R is at 77.89%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
